Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of HAT1, a Novel Topical Therapeutic: An Open Label Pilot Study of HAT1 Compared to Calcipotriol in Patients With Chronic Plaque Psoriasis

NCT03069144 is registered in ClinicalTrials.gov with Haus Bioceuticals as lead sponsor.

NCT NCT03069144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03069144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of HAT1, a Novel Topical Therapeutic: An Open Label Pilot Study of HAT1 Compared to Calcipotriol in Patients With Chronic Plaque Psoriasis
Lead sponsor
Haus Bioceuticals
Phase
Phase 1/2
Overall status
Completed
Start date
January 6, 2012
Completion date
May 28, 2012
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriasis vulgaris